EX-23.1 2 c06286b7exv23w1.htm EX-23.1

EX-23.1

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Cumberland Pharmaceuticals Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

Nashville, Tennessee

March 18, 2009